Product Information
MITIGARE 0.6 MG CAPSULE is a brand product labeled by Hikma Specialty USA Inc., priced at $6.0351 per EA under NDC 59467031830. Its NADAC has been published 407 times since Sep 12, 2018.
The High Outlier badge above means this manufacturer's average price in the Colchicine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.6 mg/1
Manufacturer
Hikma Specialty USA Inc.NDC
59467031830
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
COLCHICINEApproval Type
New Drug (NDA)
FDA Application
NDA204820On Market Since
10/1/2014
Pharmacological Classes
Price Statistics
The NADAC for MITIGARE 0.6 MG CAPSULE has been published 407 times since Sep 12, 2018, and over the history we have for it it has risen 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.0351 per EA |
|---|---|
| All-time high | $6.0603 (Jun 14, 2023) |
| All-time low | $5.7281 (Jun 17, 2020) |
| 52-week high | $6.0434 |
| 52-week low | $6.0158 |
| Median price | $6.0310 |
| Average price | $5.9481 |
| Largest weekly change | +5.5% (Feb 10, 2021) |
| Weeks tracked | 407 |
| Tracking since | Sep 12, 2018 |
Generic Alternatives
The matcher finds 17 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MITIGARE 0.6 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MITIGARE 0.6 MG CAPSULE, manufactured by Hikma Specialty USA Inc., is $6.0351 per EA (NDC 59467031830), effective Jun 24, 2026.
How has the price of MITIGARE 0.6 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MITIGARE 0.6 MG CAPSULE has risen 5.0%. It has been tracked across 407 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for MITIGARE 0.6 MG CAPSULE?
Since Sep 12, 2018, the NADAC for MITIGARE 0.6 MG CAPSULE has ranged from a low of $5.7281 (Jun 17, 2020) to a high of $6.0603 (Jun 14, 2023), with a median of $6.0310 per EA.
Are there cheaper alternatives to MITIGARE 0.6 MG CAPSULE?
Yes. 17 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, COLCHICINE 0.6 MG TABLET, is $0.1287 per EA — about 98% below MITIGARE 0.6 MG CAPSULE.
Who manufactures MITIGARE 0.6 MG CAPSULE?
MITIGARE 0.6 MG CAPSULE (NDC 59467031830) is labeled by Hikma Specialty USA Inc., and CMS classifies it as a brand product.